Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2008
10/15/2008CN100425607C Method for controlling particular insects by applying anthranilamide compounds
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425594C PPAR-activating compound and pharmaceutical composition comprising the compound
10/15/2008CN100425592C Indole derivatives
10/14/2008US7435824 Prodrugs of potassium channel inhibitors
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435822 Delta and mu opioid receptors modulators, agonist or antagonist; analgesics, immunosuppressants, antiinflammatory agents; 3-(Phenyl-thiophen-3-yl-methylene)-8-aza-bicyclo[3.2.1]octane; ; neurological and psychiatric conditions; drug and alcohol abuse,; gastritis; diarrhea; cardiovascular; respiratory
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435753 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; Coupling of an aryldiazonium salt with a 2,3-dicyano-3-cyclopropyl propanoate; parasiticides; fleas; Extended duration of action for at least 28 days
10/14/2008US7435751 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435738 Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
10/14/2008US7435733 Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
10/14/2008US7435731 Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435728 Pyrazole derivatives
10/14/2008CA2445145C Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2222138C Method of preparing 3-haloalkyl-1h-pyrazoles
10/09/2008WO2008121877A2 Cftr inhibitor compounds and uses thereof
10/09/2008WO2008121686A1 Sub-type selective azabicycloalkane derivatives
10/09/2008WO2008121670A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008WO2008121592A2 Acetyl coenzyme a carboxylase inhibitors
10/09/2008WO2008120759A1 Urea compound and use thereof
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008120655A1 Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type i
10/09/2008WO2008119771A2 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
10/09/2008WO2008119657A1 Imidazolidinone derivatives
10/09/2008WO2008086188A3 Thiophene carboxamides as factor xa inhibitors
10/09/2008WO2008081247A3 A process for the preparation of secotaxanes
10/09/2008WO2007149478A3 Pyrazine derivatives with extended conjugation and uses thereof
10/09/2008WO2007124424A3 Il-8 receptor antagonists
10/09/2008WO2007112457A3 Aprepitant polymorph mixtures
10/09/2008US20080249301 Regioselective Process for Preparing Benzimidazole Thiophenes
10/09/2008US20080249126 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals
10/09/2008US20080249115 small molecule, non-peptide, modulators (e.g., antagonists or agonists) of peptide hormones; treating low blood pressure or an eating disorder
10/09/2008US20080249110 Novel Substituted 3-Sulfur Indoles
10/09/2008US20080249095 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas
10/09/2008US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid
10/09/2008US20080249092 3-(phenylsulfonyl)-N-(tetrahydro-2H-pyran-4-ylmethyl)-8-quinolinamine; selectively modulating the cannabinoid 2 receptor; treatment of CNS disorders
10/09/2008US20080249091 Indoles Useful in the Treatment of Inflammation
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008US20080249081 Compounds for the treatment of pain and screening methods therefor
10/09/2008US20080249079 Pyrimidine Derivatives As Kinase Modulators and Method of Use
10/09/2008US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide
10/09/2008CA2682629A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2679728A1 Sub-type selective azabicycloalkane derivatives
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1978012A1 Alternative synthesis of renin inhibitors and intermediates thereof
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976847A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors
10/08/2008EP1976838A1 Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative
10/08/2008EP1976837A1 Dicarbonylic compounds with antibacterial activity
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976829A2 N-(6-membered aromatic ring)-amido anti-viral compounds
10/08/2008EP1976512A1 Novel thiophene derivatives as s1p1/edg1 receptor agonists
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1592675B1 Crystalline modifications of triazinylaminostilbenes
10/08/2008EP1569931B1 Heterocyclic compounds as ccr5 antagonists
10/08/2008EP1485363B1 Cyclic amides
10/08/2008EP1478628B1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282968A Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
10/08/2008CN101282949A Azole and thiazole derivatives and their use
10/08/2008CN101282948A Phosphatidylinositol 3-kinase inhibitors and methods of their use
10/08/2008CN101282943A Pyrimidine amide compounds as PGDS inhibitors
10/08/2008CN101282938A Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/08/2008CN101279972A Benzoxazole herbicides and preparation thereof
10/08/2008CN100424080C Quinoxaline derivatives as neutrophil elastase inhibitors and their use
10/08/2008CN100424079C Bis-sulfonamides
10/07/2008US7432392 Ester derivatives and medical use thereof
10/07/2008US7432383 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432377 of preparing 4-substituted quinoline compounds as intermediates in the manufacture of receptor tyrosine kinase inhibitors and intermediate compounds used in the methods thereof, wherein the 4-substituted quinoline compound has the following general formula (I):
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432372 Fluorinated resorufin compounds and their application
10/07/2008US7432293 Heterocyclic compounds useful as Nurr-1 activators
10/07/2008US7432291 Anticancer, antitumor agents; compounds are 1-(2-(phenethenyl)oxazol-4-ylmethoxy)-4-(1,2,3-triazolylethoxymethyl)-benzenes or corresponding derivatives where oxazole is replaced by thiazole
10/07/2008US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944
10/07/2008US7432288 Pyrrole-2,5-dione derivatives as Liver X receptor modulators
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432271 Atherosclerosis; anticholesterol agents; cardiovascular disorders; stroke; thrombosis; hypotensive agents; restenosis; antidiabetic agents; antiarthritic agents; anticancer agnets; inflammatory bowel disorders
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432269 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2433772C Pyrimidine matrix metalloproteinase inhibitors
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2248143C Process to prepare oxazolidinones
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/02/2008WO2008117982A1 Heterocyclic carboxylic acid derivatives and pharmaceutical composition for inhibiting lipid accumulation containing same
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 647